Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Radiation Oncology
•
Stereotactic Body Radiotherapy
What are your policies/practices for physician role of SBRT/SABR treatment delivery?
Related Questions
Would you consider splenic radiation in stage IV CD5+ DLBCL involving the bone marrow in patients who initially presented with symptomatic splenomegaly, anemia, and thrombocytopenia but achieved complete response on PET after 6 cycles of R-miniCHOP?
How do you counsel patients with Stage IIIA EGFR+ lung cancer regarding treatment intent with concurrent chemoRT + consolidative systemic therapy?
Is there a field size limitation for FFF beams?
In which settings would you use external beam radiotherapy for retinoblastoma in the upfront (new diagnosis) setting?
Do you prescribe prophylactic steroids to patients receiving radiosurgery for AVMs?
Is moderately hypofractionated RT using 60 Gy/20fx with concurrent chemotherapy appropriate for unresectable stage III NSCLC?
How do you decide between internal versus external decompression of malignant obstruction of the ureter (MUO)?
When would you opt to manage anal squamous cell carcinoma, HPV+ with surveillance vs adjuvant treatment following a trans-anal excision?
Why do we tend to boost grade 3 DCIS, but not grade 1 invasive disease?
How do you treat Stage IIIC T4N3 NSCLC?
